Provided by Tiger Trade Technology Pte. Ltd.

Information

5.70
-0.0400-0.70%
Post-market: 5.700.00000.00%19:30 EDT
Volume:212.31K
Turnover:1.21M
Market Cap:275.96M
PE:23.76
High:5.80
Open:5.77
Low:5.63
Close:5.74
52wk High:6.45
52wk Low:3.74
Shares:48.41M
Float Shares:35.55M
Volume Ratio:0.59
T/O Rate:0.60%
Dividend:0.18
Dividend Rate:3.16%
EPS(TTM):0.2399
EPS(LYR):0.1900
ROE:12.30%
ROA:6.36%
PB:2.88
PE(LYR):30.00

Loading ...

OHB Pediatrics to go public through Research Alliance Corporation III pact

TIPRANKS
·
Jul 27

AstraZeneca says CLARITY-Gastric01 Phase III trial met dual primary endpoint

TIPRANKS
·
Jul 27

InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study

GlobeNewswire
·
Jul 27

InnoCare’s Oral Psoriasis Drug ICP‑488 Hits Phase III Target, Paving Path to Regulatory Filing

TIPRANKS
·
Jul 27

Novartis: Balanced Upside Potential and Execution Risks Lead Analyst to Maintain Hold Rating Ahead of Key Phase III Readouts

TIPRANKS
·
Jul 27

Transcend Information Logs NT$20 Billion Profit in H1

MT Newswires Live
·
Jul 27

Inspur Electronic Information Industry Issues 1 Billion Yuan of Five-Year Bonds

MT Newswires Live
·
Jul 27

ASX Midday Sector Update: Information Technology Stocks Jump, Energy Sector Struggles

MT Newswires Live
·
Jul 27

Ipsen’s Bylvay misses Phase III goal in biliary atresia, limiting expansion bid

TIPRANKS
·
Jul 24

Biokin Pharma Enrolls First Subject in Phase III Clinical Trial of Breast Cancer Drug

MT Newswires Live
·
Jul 24

ASX Midday Sector Update: Energy Stocks Rise, Information Technology Sector Struggles

MT Newswires Live
·
Jul 24

Bank of Queensland Releases Quarterly APRA Basel III Pillar 3 Disclosures

TIPRANKS
·
Jul 24

Press Release: Cadre Holdings Announces Second Quarter 2026 Earnings and Conference Call Information

Dow Jones
·
Jul 24

Dorsey wants Buzz to loosen Slack’s hold on workers, The Information says

TIPRANKS
·
Jul 23

Shinhan Financial Group to Issue KRW Write-Down Contingent Capital Securities for Basel III Capital

TIPRANKS
·
Jul 23

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

Deep News
·
Jul 23

Grand Pharma's Traditional Chinese Medicine Innovation GPN01360 for Depression Enters Phase III with First Patient Dosed in China

Stock News
·
Jul 23

Inspur Electronic Information Industry Commits 100 Million Yuan in AI-Focused Fund

MT Newswires Live
·
Jul 23

Zydus Lifesciences Gets India Nod for Phase III Desidustat Trial in Sickle Cell Disease

MT Newswires Live
·
Jul 23

ISG Says German Firms Increasingly Tap Managed Cybersecurity Providers Amid Talent Shortages, Regulation

Reuters
·
Jul 23